"Colitis, Ulcerative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN.
| Descriptor ID |
D003093
|
| MeSH Number(s) |
C06.405.205.265.231 C06.405.205.731.249 C06.405.469.158.188.231 C06.405.469.432.249
|
| Concept/Terms |
Colitis, Ulcerative- Colitis, Ulcerative
- Idiopathic Proctocolitis
- Ulcerative Colitis
- Colitis Gravis
- Inflammatory Bowel Disease, Ulcerative Colitis Type
|
Below are MeSH descriptors whose meaning is more general than "Colitis, Ulcerative".
Below are MeSH descriptors whose meaning is more specific than "Colitis, Ulcerative".
This graph shows the total number of publications written about "Colitis, Ulcerative" by people in this website by year, and whether "Colitis, Ulcerative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 5 | 1 | 6 |
| 1994 | 4 | 2 | 6 |
| 1995 | 8 | 0 | 8 |
| 1996 | 5 | 3 | 8 |
| 1997 | 3 | 0 | 3 |
| 1998 | 8 | 2 | 10 |
| 1999 | 4 | 2 | 6 |
| 2000 | 6 | 0 | 6 |
| 2001 | 8 | 2 | 10 |
| 2002 | 6 | 1 | 7 |
| 2003 | 13 | 1 | 14 |
| 2004 | 12 | 1 | 13 |
| 2005 | 7 | 4 | 11 |
| 2006 | 16 | 1 | 17 |
| 2007 | 12 | 4 | 16 |
| 2008 | 11 | 2 | 13 |
| 2009 | 10 | 3 | 13 |
| 2010 | 9 | 0 | 9 |
| 2011 | 22 | 3 | 25 |
| 2012 | 12 | 1 | 13 |
| 2013 | 15 | 2 | 17 |
| 2014 | 8 | 0 | 8 |
| 2015 | 7 | 4 | 11 |
| 2016 | 21 | 5 | 26 |
| 2017 | 17 | 4 | 21 |
| 2018 | 13 | 1 | 14 |
| 2019 | 18 | 5 | 23 |
| 2020 | 22 | 2 | 24 |
| 2021 | 26 | 1 | 27 |
| 2022 | 27 | 0 | 27 |
| 2023 | 11 | 0 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Colitis, Ulcerative" by people in Profiles.
-
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open. Inflamm Bowel Dis. 2023 09 01; 29(9):1370-1379.
-
Treatment of Chronic Inflammatory Pouch Conditions With Tofacitinib: A Case Series From 2 Tertiary IBD Centers in the United States. Inflamm Bowel Dis. 2023 09 01; 29(9):1504-1507.
-
(Re)Appraising Remission in Ulcerative Colitis. Inflamm Bowel Dis. 2023 08 01; 29(8):1317-1326.
-
A randomised, double-blind, placebo-controlled study of the LAG-3-depleting monoclonal antibody GSK2831781 in patients with active ulcerative colitis. Aliment Pharmacol Ther. 2023 Aug; 58(3):283-296.
-
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21). BMC Med Res Methodol. 2023 05 25; 23(1):129.
-
Trends in Medical Management of Moderately to Severely Active Ulcerative Colitis: A Nationwide Retrospective Analysis. Inflamm Bowel Dis. 2023 05 02; 29(5):695-704.
-
Looking from the Past to the Future: How Janus Kinase Inhibitors Have Altered the Therapy of Ulcerative Colitis. Dig Dis Sci. 2023 06; 68(6):2248-2251.
-
Upadacitinib Is Effective and Safe in Both Ulcerative Colitis and Crohn's Disease: Prospective Real-World Experience. Clin Gastroenterol Hepatol. 2023 Jul; 21(7):1913-1923.e2.
-
Assessment of the Degree of Variation of Histologic Inflammation in Ulcerative Colitis. Inflamm Bowel Dis. 2023 02 01; 29(2):222-227.
-
Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Inflamm Bowel Dis. 2023 02 01; 29(2):286-296.